Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Emcure Pharma Review: Jefferies, Kotak Maintain Buy; Raise Growth Estimates

    1 day ago

    Emcure Pharmaceuticals' Q2 performance and improving growth outlook have prompted Jefferies and Kotak to maintain their Buy ratings.
    Click here to Read More
    Previous Article
    SBI, BEL Among Nine Stocks In HDFC Securities' Q2 Review; Sees Upside Of Up To 67%; Check New Target Prices
    Next Article
    'Schools Are In Control': Google Breaks Silence Amid Row Over Search Access

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment